NeoDiagnostix
	Operator of a cancer diagnostics company. The company uses molecular DNA technologies with a substantial portfolio of proprietary biomarkers. The company provides clinicians with a patient\'s molecular profile that provides crucial insights into cancer leading to improved patient care.
	['', 'cancer diagnostics', ' DNA ', 'molecular profile', '']
Satoris
	Provider of molecular diagnostics product meant for the test of Alzheimer\'s disease. The company uses molecular biology and bioinformatics to develop test and treatment meant for Alzheimer\'s disease.
	['', 'medical supplies', ' ', 'drug discovery', '']
Xceed Molecular
	Developer of expression-based molecular diagnostic products. The company is working on the speed, simplicity, and efficiency of expression-based molecular diagnostics through its “Ziplex™” Automated Workstation. The Ziplex uses the company\'s flow-thru-chip microarray technology to perform highly multiplexed molecular assays faster and at a lower cost than conventional array systems, while providing simplicity of use that is essential for broader adoption of molecular diagnostics.
	['', 'molecular diagnostics', ', expression-based', '']
Zyentia
	Operator of a biotechnology company focused on treatment of protein-folding disorders. The company researches the molecular determinants underlying protein misfolding, aggregation and deposition in the tissue. The company applies its research to development of therapies for a variety of protein-misfolding disorders, including Type 2 Diabetes, Alzheimer\'s disease and Parkinson disease.
	['', 'molecular determinants', ' ', 'protein misfolding', ' aggregation tissue']
Ceregene
	Developer of treatments for neurodegenerative disorders. The company is a biotechnology enterprise ocused on the treatment of major neurodegenerative disorders using the delivery of nervous system growth factors. Its clinical programs include CERE-110, an AAV2-based vector expressing nerve growth factor, for the treatment of Alzheimer’s disease; and CERE-120, in trials as a treatment for  Parkinson’s disease. The company also has two treatments - CERE-135 and CERE-140 - in preclinical development for amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease) and ocular diseases, respectively.
	['', 'neurotrophic growth treatment', ' ', 'translational medicine', ' ', 'neurodegenerative disorder', ' biopharmaceutical']
EnviroGene
	Provider of molecular diagnostics related to environmental pollution. The company provides environmentally friendly tracer systems to identify sources of fecal and microbial contamination in water bodies.
	['', 'molecular diagnostic', ' ', 'natural resources management', ' ', 'contamination test', ' ', 'Environmental Service', '']
Galantos Pharma
	Developer of novel drugs for the treatment of Alzheimer‘s Disease and other neurodegenerative diseases. The company is developing Memogain, a derivative  of the plant alkaloid galantamine, for symptomatic and disease-modifying treatment of Alzheimer‘s dementia (AD).
	['', 'novel drugs', ' ', 'neurodegenerative diseases', 'cholinergic', 'brain enzymes', ' ', 'Alzheimer‘s Disease', '']
Rinat Neuroscience
	Developer of protein-based therapeutics for the treatment of diseases and disorders of the nervous system. The company is developing neuroscience-based protein therapeutics for pain, Alzheimer\'s disease, obesity and diabetes, and neuropathies. It is also developing novel disease modifying therapies that modulate the function, as well as prevent and reverse the damage to key populations of neurons specifically affected in particular disease states.
	['', 'protein therapeutic', ' ', 'Alzheimer disease', ' ', 'nervous system', ' ', 'biotech community', '']
NovioGendix
	Provider of molecular diagnostics and services to physicians, clinics, and hospitals. The company offers service to conduct test for prostate cancer and developing molecular diagnostic assays for uro-oncological practices and cancer treatment.
	['', 'molecular diagnostic', ' ', 'laboratory service', ' ', 'kidney cancer', ' ', 'uro-oncological disease', '']
Apollo BioPharmaceutics
	Developer of drugs that protect brain cells from damage caused by disease, injury and aging. The company\'s target applications include the treatment of Alzheimer\'s disease, Parkinson\'s disease, brain damage resulting from stroke and other age-related diseases and conditions.
	['biotechnology ', 'life science', ' ', "Alzheimer\\'s disease", ' ', "Parkinson\\'s disease", '']
